Age-dependent levels of select immunological mediators in sera of healthy children

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 1, 1998, Pages 28-32

  Sack, Ulrich ^a   Burkhardt, Ullrich ^a   Borte, Michael ^a   Schädlich, Hiltrud ^a   Berg, Kerstin ^a   Emmrich, Frank ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

AGE; ARTICLE; BLOOD LEVEL; CHILD; DIAGNOSTIC VALUE; HUMAN; INFECTION; INFLAMMATION; NORMAL HUMAN; PRIORITY JOURNAL; STANDARDIZATION; TIME;

EID: 0031882608     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.1.28-32.1998     Document Type: Article

References (40)

1. Adams, D. H., L. Wang, S. G. Hubscher, E. Elias, and J. M. Neuberger. 1978. Soluble interleukin-2 receptors in serum and bile of liver transplant recipients. Lancet i:469-471.
2. Anonymous. 1988. Neopterins in clinical medicine. Lancet 1:509-511.
3. Babson, A. L. 1991. The Immulite automated immunoassay system. J. Clin. Immunoassay 14:83-88.
4. Baron, D., S. K. Tyring, W. R. Fleischmann, D. H. Coppenhaver. D. W. Niesel, G. R. Klimpel. G. J. Stanton, and T. K. Hughes. 1991. The interferons: mechanisms of action and clinical application. JAMA 266:1375-1383.
5. Beutler, B., and A. Ccrami. 1988. Tumor necrosis, cachexia. shock, and inflammation: a common mediator. Annu. Rev. Biochem. 57:505-518.
6. Brailly. H., F. A. Montero-Julian, C. E. Zuber, S. Flavetta, J. Grassi, F. Houssiau, and J. van Snick. 1994. Total interleukin-6 in plasma measured by immunoassay. Clin. Chem. 40:110-123.
7. Cetinguil, N., E. Yener, S. Oztop, and G. Nisli. 1994. Serum soluble interleukin-2 receptors and tumor necrosis factor-alpha in hematological malignancies of childhood. Acta Paediatr. Jpn. 36:49-52.
8. K. Chan, K. N., A. D. Phillips, J. A. Walker-Smith, and T. T. MacDonald. 1995 Serum interleukin-2 receptors in infants and young children. Acta Paediatr. 84:151-155.
9. Daniel, V. 1995. Diagnostic value of cytokine determination in serum and plasma. Dtsch. Med. Woehenschr. 120:1171-1174.
10. Dinarello, C. D. 1992. Role of intcrleukin-1 in infectious diseases. Immunol. Rev. 127:119-146.
11. Dodds, R. A., K. Merry, A. Littlewood, and M. Gowen. 1994. Expression of mRNA for IL 1 beta, IL6 and TGF beta I in developing human bone and cartilage. J. Histochem. Cytoehem. 42:733-744.
12. Fuchs, D., G. Weiss, G. Reibnegger, and H. Wachter. 1992. The role of neoptcrin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit. Rev. Clin. Lab. Sci. 29:307-341.
13. Gearing, A. J., and W. Newman. 1993. Circulating adhesion molecules in disease. Immunol. Today 14:506 512.
14. Griffin. D. E., B. J. Ward, E. Jluregui, R. T. Johnson, and A. Vaisberg. 1990. Immune activation during measles: interferon-gamma and neoplerin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J. Infect. Dis. 161:449-453.
15. Grob, P. M., E. David, T. C. Warren, R. P. DeLeon, P. R. Farina, and C. A. Homon. 1990. Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. J. Biol. Chem. 265:8311-8316.
16. Hannum, C. H., C. J. Wileox, W. P. Arend, F. G. Joslin, D. J. Dripps, P. L. Heimdal, L. G. Armes, A. Sommer, S. P. Eisenberg, and R. C. Thompson. 1990. Intcrlcukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340.
17. Haran, N., Y. Bar-Khayim, A. Frensdorff, and G. Barnard. 1991. Tumor necrosis factor (TNF-alpha) binding protein: interference in immunoassays of TNF-alpha. Kidney Int. 40:1116-1170.
18. Hatzistilianou, M., F. Athanassiadou, C. Agguridaki, and D. Catriu. 1997. Circulating soluble adhesion molecules in children with acute lymphoblastic leukaemia. Eur. .J. Pediatr. 156:537-540.
19. Hession, C., L. Osborn, D. Goff, G. Chi-Rosso, C. Vassallo, M. Pasek, C. Pittack, R. Tizard, S. Goelz, and K. McCarthy. 1990. Endothelial leukocyte adhesion molecule I: direct expression cloning and functional interactions. Proc. Natl. Acad. Sci. USA 87:1673-1677.
20. Hirano, T., S. Akira, T. Taga, and T. Kishimoto. 1990. Biological and clinical aspects of interleukin 6. Immunol. Today 11:443-449.
21. Ishii, E., S. Ohga, S. Yamada, M. Sako, H. Tasaka, A. Kuwano, M. Sasaki, Y. Tsunematsu, and K. Ueda. 1991. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Hacmatol, Jpn. 85:93-99.
22. Jacob, C. O. 1992. Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? Immunol. Today 13:122-125.
23. Jones. A. C., C. R. Besley, J. A. Warner, and J. O. Warner. 1994. Variations in serum soluble 1L-2 receptor concentration. Pediatr. Allergy Immunol. 5:230-234.
24. Junes, E. Y., D. I. Stuart, and N. P. C. Walker. 1989 Structure of the tumour necrosis factor. Nature 338:225-228.
25. Krüger, C., C. Schütt, H. Dietz, J. Lüdtke, Bi. Ruf, A. Langford, H. D. Pohle, and R. O. F. Kunze. 1990. Elevated levels of soluble CD14 molecules in scrum of HIV-I infected patients. Immunohiology 181:244.
26. Krüger, C., C. Schutt, U. Obertacke, T. Joka, F. E. Müller, J. Knöller, W. Knöller, and W. Schönfled. 1991. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 85:297-301.
27. Lantz, M., H. Thysell, E, Nilsson, and I. Olsson. 1991. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-hinding protein I by heparin. J. Clin. Invest. 88:2026-2031.
28. Pirenne, J., F. Pirenne-Noizat, D. de Groote, Y. Vrindts, M. Lopez, R. Gathy, N. Jacquet, M. Meurisse, P. Honore, and P. Franchimonl. 1994. Cytokines and organ transplantation: a review. Nucl. Med. Biol. 21:545-555.
29. Prader, A., R. H. Largo, L. Molinari, and C. Issler. 1988. Physical growth of Swiss children from birth to 20 years of age. Helv. Pacdiatr. Acta 43(Suppl. 52):124-125.
30. Rubin, L. A., and D. L. Nelson. 1990. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann. Inlern. Med. 113:619-627.
31. Smith, C. W., R. Rothlein, B. J. Hughes, M. M. Mariscalco, H. E. Rudloff, F. C. Schmalstieg, and D. C. Anderson. 1988. Recognition of an cndothelial determinant for CD18-dependent human neulrophil adherence and transendothclial migration. .1. Clin. Invest. 82:1746-1756.
32. Smith, R. A., and C. Baglioni. 1987. The active form of tumor necrosis factor is a trimcr. .1. Biol. Chem. 262:6951-6954.
33. Sprang, S. R. 1991. The divergent receptors for TNF. Trends Biochem. Sci. 15:366-368.
34. Springer, T. A. 1990. Adhesion receptor of the immune system. Nature 346:425-434.
35. Subramaniam, M., S. Saffaripour, L. van de Water, P. S. Frenette, T. N. Mayadas, R. O. Hynes, and D. D. Wagner. 1997. Role of endothelial sclectins in wound repair. Arn. J. Palhol. 150:1701-1709.
36. Tartaglia, L. A., and D. V. Goeddel. 1992. Two TNF receptors, Immunol. Today 13:151-153.
37. Tracey, K. J., H. Vlassara, and A. Cerami. 1989. Cacheclin/tumour necrosis factor. Lancet 1:1122-1126.
38. Waldmann, T. A. 1991. The interlcukin-2 receptor. J. Biol. Chem. 266:2681-2684.
39. Wciss, M., M. Martignoni, T. Petropoulou, B. Solder, and B. H. Belohrad-sky. 1996. Increased serum levels of soluble tumor necrosis factor receptor (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection. Infection 24:301-308.
40. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.